Cefazolin Pharmacokinetics in Premature Infants

OBJECTIVE: Pharmacokinetic (PK) data to guide cefazolin dosing in premature infants is virtually non-existent. Therefore, we aimed to characterize cefazolin PK in infants aged ≤32 weeks of gestation at birth. STUDY DESIGN: We conducted a prospective, open-label PK and safety study of cefazolin in in...

Descripción completa

Detalles Bibliográficos
Autores principales: Balevic, Stephen J., Smith, P. Brian, Testoni, Daniela, Wu, Huali, Brouwer, Kim L.R., Zimmerman, Kanecia O., Rivera-Chaparro, Nazario D., Benjamin, Daniel K., Cohen-Wolkowiez, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713589/
https://www.ncbi.nlm.nih.gov/pubmed/30944398
http://dx.doi.org/10.1038/s41372-019-0368-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713589/
https://www.ncbi.nlm.nih.gov/pubmed/30944398
http://dx.doi.org/10.1038/s41372-019-0368-z

Ejemplares similares